Literature DB >> 15958699

Hematopoietic stem cell transplantation across major genetic barriers: tolerance induction by megadose CD34 cells and other veto cells.

Yair Reisner1, Hilit Gur, Shlomit Reich-Zeliger, Massimo F Martelli, Esther Bachar-Lustig.   

Abstract

Studies in mice and humans demonstrate that transplantation of hematopoietic progenitors in numbers larger than commonly used overcomes major genetic barriers. In vitro studies suggest that veto cells, within the population of hematopoietic progenitors, facilitate this favorable outcome. Tolerance induction can be further enhanced by other veto cells. Perhaps the most potent veto cell is the CD8(+) CTL. However, this cell is also associated with marked GVHD, which can be separated from the veto activity by generating anti-third party CTLs under IL-2 deprivation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15958699     DOI: 10.1196/annals.1349.010

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

Review 1.  Lymphoid reconstruction and vaccines.

Authors:  Ronald E Gress; Krishna V Komanduri; Hermann Einsele; Laurence J N Cooper
Journal:  Biol Blood Marrow Transplant       Date:  2007-01       Impact factor: 5.742

Review 2.  Translational studies in hematopoietic cell transplantation: treatment of hematologic malignancies as a stepping stone to tolerance induction.

Authors:  Samuel Strober; Thomas R Spitzer; Robert Lowsky; Megan Sykes
Journal:  Semin Immunol       Date:  2011-06-25       Impact factor: 11.130

3.  Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions.

Authors:  Hongtao Liu; Elizabeth S Rich; Lucy Godley; Olatoyosi Odenike; Loren Joseph; Susana Marino; Justin Kline; Vu Nguyen; John Cunningham; Richard A Larson; Paula del Cerro; Linda Schroeder; Lisa Pape; Wendy Stock; Amittha Wickrema; Andrew S Artz; Koen van Besien
Journal:  Blood       Date:  2011-10-05       Impact factor: 22.113

Review 4.  Immune tolerance and transplantation.

Authors:  Onder Alpdogan; Marcel R M van den Brink
Journal:  Semin Oncol       Date:  2012-12       Impact factor: 4.929

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.